Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Orkambi on Exertional Dyspnea, Exercise Performance, and Ventilatory Responses in Adults With Cystic Fibrosis

NCT02821130 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT02821130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02821130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Orkambi on Exertional Dyspnea, Exercise Performance, and Ventilatory Responses in Adults With Cystic Fibrosis
Lead sponsor
University of British Columbia
Phase
Observational
Overall status
Completed
Start date
July 31, 2016
Completion date
June 1, 2020
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis, lung; disease